Prestige Consumer Healthcare
PBH
#4268
Rank
A$3.84 B
Marketcap
A$79.94
Share price
-0.54%
Change (1 day)
-36.58%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): A$5.84

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.32. In 2024 the company made an earnings per share (EPS) of A$6.01 an increase over its 2023 EPS that were of A-$2.25.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$5.84-2.78%
2024A$6.01-367.08%
2023A-$2.25-138.33%
2022A$5.8711.7%
2021A$5.2513.6%
2020A$4.63-651.67%
2019A-$0.84-148.78%
2018A$1.72-83.29%
2017A$10.28437.23%
2016A$1.91-34.13%
2015A$2.9152.94%
2014A$1.90-8.11%
2013A$2.07
2011A$1.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.56 192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$9.66 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.06 88.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.90-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.24-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.59 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$1.97-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.27-1.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$41.39-877.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.70-67.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel